DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Fosmidomycin is an investigational drug.
There have been 7 clinical trials for Fosmidomycin. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2005.
The most common disease conditions in clinical trials are Malaria, Malaria, Falciparum, and [disabled in preview]. The leading clinical trial sponsors are Jomaa Pharma GmbH, Albert Schweitzer Hospital, and Thammasat University.
Recent Clinical Trials for Fosmidomycin
|Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria||Centre de Recherche Médicale de Lambaréné||Phase 2|
|Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria||Jomaa Pharma GmbH||Phase 2|
|Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria||Albert Schweitzer Hospital||Phase 2|